BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 28470962)

  • 1. Do patients have worse outcomes in heart failure than in cancer? A primary care-based cohort study with 10-year follow-up in Scotland.
    Mamas MA; Sperrin M; Watson MC; Coutts A; Wilde K; Burton C; Kadam UT; Kwok CS; Clark AB; Murchie P; Buchan I; Hannaford PC; Myint PK
    Eur J Heart Fail; 2017 Sep; 19(9):1095-1104. PubMed ID: 28470962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. More 'malignant' than cancer? Five-year survival following a first admission for heart failure.
    Stewart S; MacIntyre K; Hole DJ; Capewell S; McMurray JJ
    Eur J Heart Fail; 2001 Jun; 3(3):315-22. PubMed ID: 11378002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term trends in first hospitalization for heart failure and subsequent survival between 1986 and 2003: a population study of 5.1 million people.
    Jhund PS; Macintyre K; Simpson CR; Lewsey JD; Stewart S; Redpath A; Chalmers JW; Capewell S; McMurray JJ
    Circulation; 2009 Feb; 119(4):515-23. PubMed ID: 19153268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anemia and associated clinical outcomes in patients with heart failure due to reduced left ventricular systolic function.
    McCullough PA; Barnard D; Clare R; Ellis SJ; Fleg JL; Fonarow GC; Franklin BA; Kilpatrick RD; Kitzman DW; O'Connor CM; Piña IL; Thadani U; Thohan V; Whellan DJ;
    Clin Cardiol; 2013 Oct; 36(10):611-20. PubMed ID: 23929781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex-Specific Epidemiology of Heart Failure Risk and Mortality in Europe: Results From the BiomarCaRE Consortium.
    Magnussen C; Niiranen TJ; Ojeda FM; Gianfagna F; Blankenberg S; Vartiainen E; Sans S; Pasterkamp G; Hughes M; Costanzo S; Donati MB; Jousilahti P; Linneberg A; Palosaari T; de Gaetano G; Bobak M; den Ruijter HM; Jørgensen T; Söderberg S; Kuulasmaa K; Zeller T; Iacoviello L; Salomaa V; Schnabel RB;
    JACC Heart Fail; 2019 Mar; 7(3):204-213. PubMed ID: 30819375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between Comorbidities and Outcomes in Heart Failure Patients With and Without an Implantable Cardioverter-Defibrillator for Primary Prevention.
    Khazanie P; Hellkamp AS; Fonarow GC; Bhatt DL; Masoudi FA; Anstrom KJ; Heidenreich PA; Yancy CW; Curtis LH; Hernandez AF; Peterson ED; Al-Khatib SM
    J Am Heart Assoc; 2015 Aug; 4(8):e002061. PubMed ID: 26251283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival differences between heart failure in general practices and in hospitals.
    Nielsen OW; Hilden J; McDonagh T; Fischer Hansen J
    Heart; 2003 Nov; 89(11):1298-302. PubMed ID: 14594883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Atrial Fibrillation on Mortality, Stroke Risk, and Quality-of-Life Scores in Patients With Heart Failure (from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF]).
    Cherian TS; Shrader P; Fonarow GC; Allen LA; Piccini JP; Peterson ED; Thomas L; Kowey PR; Gersh BJ; Mahaffey KW
    Am J Cardiol; 2017 Jun; 119(11):1763-1769. PubMed ID: 28416199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality in Incident Maintenance Dialysis Patients Versus Incident Solid Organ Cancer Patients: A Population-Based Cohort.
    Naylor KL; Kim SJ; McArthur E; Garg AX; McCallum MK; Knoll GA
    Am J Kidney Dis; 2019 Jun; 73(6):765-776. PubMed ID: 30738630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Race, exercise training, and outcomes in chronic heart failure: findings from Heart Failure - a Controlled Trial Investigating Outcomes in Exercise TraiNing (HF-ACTION).
    Mentz RJ; Bittner V; Schulte PJ; Fleg JL; Piña IL; Keteyian SJ; Moe G; Nigam A; Swank AM; Onwuanyi AE; Fitz-Gerald M; Kao A; Ellis SJ; Kraus WE; Whellan DJ; O'Connor CM
    Am Heart J; 2013 Sep; 166(3):488-95. PubMed ID: 24016498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in long-term cardiovascular mortality and morbidity in men and women with heart failure of ischemic versus non-ischemic aetiology in Western Australia between 1990 and 2005.
    Teng TH; Hung J; Knuiman M; Stewart S; Arnolda L; Jacobs I; Hobbs M; Sanfilippo F; Geelhoed E; Finn J
    Int J Cardiol; 2012 Jul; 158(3):405-10. PubMed ID: 21334755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender-related dissociation in outcomes in chronic heart failure: reduced mortality but similar hospitalization in women.
    Ahmed MI; Lainscak M; Mujib M; Love TE; Aban I; Piña IL; Aronow WS; Bittner V; Ahmed A
    Int J Cardiol; 2011 Apr; 148(1):36-42. PubMed ID: 19939481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hospitalization for Recently Diagnosed Versus Worsening Chronic Heart Failure: From the ASCEND-HF Trial.
    Greene SJ; Hernandez AF; Dunning A; Ambrosy AP; Armstrong PW; Butler J; Cerbin LP; Coles A; Ezekowitz JA; Metra M; Starling RC; Teerlink JR; Voors AA; O'Connor CM; Mentz RJ
    J Am Coll Cardiol; 2017 Jun; 69(25):3029-3039. PubMed ID: 28641792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness and cost-effectiveness of serum B-type natriuretic peptide testing and monitoring in patients with heart failure in primary and secondary care: an evidence synthesis, cohort study and cost-effectiveness model.
    Pufulete M; Maishman R; Dabner L; Mohiuddin S; Hollingworth W; Rogers CA; Higgins J; Dayer M; Macleod J; Purdy S; McDonagh T; Nightingale A; Williams R; Reeves BC
    Health Technol Assess; 2017 Aug; 21(40):1-150. PubMed ID: 28774374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased risk of cancer death in patients with chronic heart failure with a special reference to inflammation-A report from the CHART-2 Study.
    Oikawa T; Sakata Y; Nochioka K; Miura M; Abe R; Kasahara S; Sato M; Aoyanagi H; Shiroto T; Sugimura K; Takahashi J; Miyata S; Shimokawa H;
    Int J Cardiol; 2019 Sep; 290():106-112. PubMed ID: 31104823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exercise-based cardiac rehabilitation for chronic heart failure: the EXTRAMATCH II individual participant data meta-analysis.
    Taylor RS; Walker S; Ciani O; Warren F; Smart NA; Piepoli M; Davos CH
    Health Technol Assess; 2019 May; 23(25):1-98. PubMed ID: 31140973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doxorubicin-induced heart failure in cancer patients: A cohort study based on the Korean National Health Insurance Database.
    Kim YA; Cho H; Lee N; Jung SY; Sim SH; Park IH; Lee S; Lee ES; Kim HJ
    Cancer Med; 2018 Dec; 7(12):6084-6092. PubMed ID: 30453386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Employment status at time of first hospitalization for heart failure is associated with a higher risk of death and rehospitalization for heart failure.
    Rørth R; Fosbøl EL; Mogensen UM; Kragholm K; Numé AK; Gislason GH; Jhund PS; Petrie MC; McMurray JJV; Torp-Pedersen C; Køber L; Kristensen SL
    Eur J Heart Fail; 2018 Feb; 20(2):240-247. PubMed ID: 29148231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in the prevalence of malignancy among patients admitted with acute heart failure and associated outcomes: a nationwide population-based study.
    Ram P; Tiu A; Lo KB; Parikh K; Shah M
    Heart Fail Rev; 2019 Nov; 24(6):989-995. PubMed ID: 31175492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients with heart failure have an increased risk of incident cancer.
    Hasin T; Gerber Y; McNallan SM; Weston SA; Kushwaha SS; Nelson TJ; Cerhan JR; Roger VL
    J Am Coll Cardiol; 2013 Sep; 62(10):881-6. PubMed ID: 23810869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.